title: Cholesterol regulates HERG K+ channel activation by increasing phospholipase C β1 expression.
abstract: Human ether-a-go-go-related gene (HERG) K(+) channel underlies the rapidly activating delayed rectifier K(+) conductance (IKr) during normal cardiac repolarization. Also, it may regulate excitability in many neuronal cells. Recently, we showed that enrichment of cell membrane with cholesterol inhibits HERG channels by reducing the levels of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] due to the activation of phospholipase C (PLC). In this study, we further explored the effect of cholesterol enrichment on HERG channel kinetics. When membrane cholesterol level was mildly increased in human embryonic kidney (HEK) 293 cells expressing HERG channel, the inactivation and deactivation kinetics of HERG current were not affected, but the activation rate was significantly decelerated at all voltages tested. The application of PtdIns(4,5)P2 or inhibitor for PLC prevented the effect of cholesterol enrichment, while the presence of antibody against PtdIns(4,5)P2 in pipette solution mimicked the effect of cholesterol enrichment. These results indicate that the effect of cholesterol enrichment on HERG channel is due to the depletion of PtdIns(4,5)P2. We also found that cholesterol enrichment significantly increases the expression of β1 and β3 isoforms of PLC (PLCβ1, PLCβ3) in the membrane. Since the effects of cholesterol enrichment on HERG channel were prevented by inhibiting transcription or by inhibiting PLCβ1 expression, we conclude that increased PLCβ1 expression leads to the deceleration of HERG channel activation rate via downregulation of PtdIns(4,5)P2. These results confirm a crosstalk between two plasma membrane-enriched lipids, cholesterol and PtdIns(4,5)P2, in the regulation of HERG channels.
authors.affiliation: Department of Physiology; Samsung Biomedical Research Institute; Sungkyunkwan University School of Medicine; Suwon, South Korea.
authors.forename: Yoon Sun
authors.initials: YS
authors.lastname: Chun
authors.forename: Hyun Geun
authors.initials: HG
authors.lastname: Oh
authors.forename: Myoung Kyu
authors.initials: MK
authors.lastname: Park
authors.forename: Hana
authors.initials: H
authors.lastname: Cho
authors.forename: Sungkwon
authors.initials: S
authors.lastname: Chung
mesh_terms: D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002784:Cholesterol / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects; D055724:Electrophysiological Phenomena / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D051638:Ether-A-Go-Go Potassium Channels / Q000378:metabolism*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D057809:HEK293 Cells; D006801:Humans; D007700:Kinetics; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000172:deficiency / Q000378:metabolism; D054799:Phospholipase C beta / Q000235:genetics* / Q000378:metabolism
chemical_list: D051638:Ether-A-Go-Go Potassium Channels; D019269:Phosphatidylinositol 4,5-Diphosphate; D002784:Cholesterol; C518033:PLCB1 protein, human; D054799:Phospholipase C beta
keywords: HERG; K+ channel; cholesterol; long QT syndrome; methyl-β-cyclodextrin; phosphatidylinositol 4,5-bisphosphate; phospholipase C